|
News for: |
|
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
FDA Approval Activities for this Drug…
VIRACEPT (nelfinavir mesylate) Tablets, 625 mg, Agouron NDA 21-503 4/30/03 | VIRACEPT (nelfinavir mesylate) Tablets and Powder, 250mg & 50mg/g Agouron NDA 20-779/S41 20-778/S20 & 21-503/S2 8/22/03 8/28/03 8/28/03 | VIRACEPT (nelfinavir mesylate) Tablets and Powder, 250mg & 50mg/g Agouron NDA 20-779/S22 4/23/03 | VIRACEPT (nelfinavir mesylate) Tablets and Powder, 250mg & 50mg/g Agouron NDA 20-778/S18 & 20-779/S39 | 12/20/02 7/30/03 4/4/03 | VIRACEPT (nelfinavir mesylate) Tablets and Powder, 250mg & 50mg/g Agouron NDA 20-778/S16, 20-778/S17, 20-779/S37 & 20-779/S38 2/5/02 4/17/02 | VIRACEPT (nelfinavir mesylate) Tablets and Powder, 250mg & 50mg/g Agouron NDA 20-778/S14, 20-779/S32 | VIRACEPT (nelfinavir mesylate) Tablets and Oral Powder, Pfizer Inc. Viracept (nelfinavir mesylate) 250 mg tablets, Pfizer | | Viracept (nelfinavir mesylate) 625 mg tablets, Pfizer | Viracept (nelfinavir mesylate) oral powder, Pfizer | VIRACEPT (nelfinavir mesylate) oral powder, Pfizer Inc., Labeling Revision | VIRACEPT (nelfinavir mesylate 250mg) tablets, Pfizer Inc., Labeling Revision | VIRACEPT (nelfinavir mesylate 625mg) tablets, Pfizer Inc., Labeling Revision
|